MRK's vs. Market share relative to its competitors, as of Q2 2024
As of Q2 2024 (Revenue in Millions of $)
Date modified: 2024-09-14T12:38:31+00:00
Select the Relationship:
Select the Category:
COMPANY NAME
REVENUES 12 Months Ending Q2 2024
MARKET SHARE 12 Months Q2 2024
MARKET SHARE MRQ Q2 2024
MARKET SHARE A Quarter Before Q1 2024
Merck and Co Inc
62,480.00
11.14%
11.18 %
11.50 %
Abbvie Inc
55,000.00
9.81%
10.03%
8.97%
Abbott Laboratories
40,725.00
7.26%
7.20%
7.26%
Enact Holdings Inc
1,185.64
0.21%
0.21%
0.21%
Amgen Inc
30,934.00
5.52%
5.82%
5.43%
Bristol myers Squibb Company
46,509.00
8.29%
8.46%
8.65%
Johnson and Johnson
86,576.00
15.44%
15.57%
15.59%
Eli Lilly And Company
38,922.80
6.94%
7.84%
6.39%
Pfizer Inc
55,642.00
9.92%
9.21%
10.85%
Procter and Gamble Co
84,039.00
14.98%
14.24%
14.72%
Gilead Sciences Inc
27,805.00
4.96%
4.82%
4.87%
Baxter International Inc
14,861.00
2.65%
2.64%
2.62%
Patterson Companies Inc
6,533.80
1.16%
1.07%
1.26%
Petvivo Holdings Inc
0.97
0.00%
0.00%
0.00%
Quantum si Incorporated
1.51
0.00%
0.00%
0.00%
Biogen Inc
9,672.00
1.72%
1.71%
1.67%
SUBTOTAL
560,887.71
100%
144,176.81
100%
MRK's vs. Market share relative to its competitors, as of Q2 2024 within the Major Pharmaceutical Preparations Industry
As of Q2 2024
MRK's vs. Market share relative to its competitors, as of Q2 2024 within the Healthcare Sector
As of Q2 2024
Submit
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com